Seconds after his crucial save, the keeper on loan from Portsmouth hauled down Brynjar Gunnarsson just as the Icelandic defender looked set to stroke into an empty net.
If AtheroGenics had set heart attack, stroke and death as the main goal of its study, these results could lead to approval by the U.S. Food and Drug Administration.